Long‐Term Efficacy of Arthroscopic Microfracture Combined With Autologous Collagen‐Induced Chondrogenesis for Knee Cartilage Defects: A 5‐Year Prospective Pilot Randomized Controlled Trial
Orthopaedic Surgery · 2026-04 · 18 (4) · 631-640
DOI: 10.1111/os.70226 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Orthopaedic Surgery, online erschienen am 25.02.2026. Verfasst von Shuofang Ren und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Arthroplasty, Subchondral, Arthroscopy, Cartilage, Articular, Chondrogenesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Objectives
Cartilage defect of the knee joint is a common cause of knee pain and can result in significant functional disability due to its limited capability of spontaneous healing. Existing surgical options—such as microfracture, cartilage or chondrocyte transplantation, and joint replacement—remain limited by inconsistent restoration of durable hyaline cartilage. Autologous collagen‐induced chondrogenesis (ACIC), which employs a collagen scaffold, has emerged as a promising single‐stage alternative. Nevertheless, high‐quality evidence evaluating its long‐term efficacy relative to microfracture alone is still lacking. This study investigates the clinical effect of arthroscopic microfracture combined with autologous collagen‐induced chondrogenesis for knee cartilage defects over a 5‐year follow‐up.
Methods
Twenty patients with knee cartilage defects were randomized to receive ACIC + microfracture ( n = 10) or microfracture alone (MF, n = 10). Outcomes were assessed using Lysholm, VAS, and IKDC scores at baseline, 1 week, 3, 6, 12 months, and 5 years, alongside MRI‐based MOCART scoring. Analyses employed linear mixed‐effects models with multiplicity correction and effect size reporting.
Results
Both groups showed significant within‐group improvements in Lysholm, VAS, and IKDC over time, but there were no between‐group differences and no significant Group × Time interactions, indicating comparable functional recovery. In contrast, the MOCART score showed a significant long‐term Group × Time interaction at 5 years ( β = 53.1, 95% CI 29.0–77.2, p < 0.001), favoring ACIC + MF. At 5 years, ACIC + MF demonstrated a large structural advantage, although the unadjusted Mann–Whitney p = 0.0196 did not remain significant after multiplicity correction (adjusted p = 0.098).
Conclusion
ACIC + MF resulted in superior long‐term structural repair compared with MF, as reflected in MOCART scores, but this did not translate into superior patient‐reported outcomes. These findings underscore the divergence between imaging‐based repair and clinical function and highlight the need for prospective trials establishing anchor‐based MCID and Patient Acceptable Symptom State (PASS) thresholds for MOCART to clarify its clinical significance. Trial Registration Chinese National Medical Research Registration and Archival Information System: ChiCTR2400080094
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
- Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
- Operating Room, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
ORCID-Profile: Bo Yang
Förderung
- National Natural Science Foundation of China CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Ren, S., Bai, Z., Lu, X., Zhang, Y., Sun, X., Tang, R., Yang, B., Qian, J., & Qiu, G. (2026). Long‐Term Efficacy of Arthroscopic Microfracture Combined With Autologous Collagen‐Induced Chondrogenesis for Knee Cartilage Defects: A 5‐Year Prospective Pilot Randomized Controlled Trial. Orthopaedic Surgery, 18(4), 631-640. https://doi.org/10.1111/os.70226
Vancouver
Ren S, Bai Z, Lu X, Zhang Y, Sun X, Tang R, et al. Long‐Term Efficacy of Arthroscopic Microfracture Combined With Autologous Collagen‐Induced Chondrogenesis for Knee Cartilage Defects: A 5‐Year Prospective Pilot Randomized Controlled Trial. Orthopaedic Surgery. 2026;18(4):631-640. doi:10.1111/os.70226
BibTeX
@article{Ren2026,
author = {Ren, Shuofang and Bai, Zhuosong and Lu, Xin and Zhang, Yan and Sun, Xu and Tang, Rui and Yang, Bo and Qian, Jun and Qiu, Guixing},
title = {Long‐Term Efficacy of Arthroscopic Microfracture Combined With Autologous Collagen‐Induced Chondrogenesis for Knee Cartilage Defects: A 5‐Year Prospective Pilot Randomized Controlled Trial},
journal = {Orthopaedic Surgery},
year = {2026},
volume = {18},
number = {4},
pages = {631--640},
doi = {10.1111/os.70226}
}
EUVIMED